Mounjaro sales double this year as obesity drug boom prevails, says maker

The manufacturer said its obesity medications Mounjaro and Zepbound were driving an acceleration of its overall sales.

Več na: https://www.standard.co.uk/news/health/china-b1292457.html

nazaj